(Q37907117)

25 August 2017

1 reference

title

Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer (English)

1 reference

Chinese Medical Association

25 August 2017

1 reference

12

object named as

Chinese Medical Association

1 reference

25 August 2017

Jianmin Xu

1

1 reference

25 August 2017

Xinyu Qin

2

1 reference

25 August 2017

Jianping Wang

3

1 reference

25 August 2017

Suzhan Zhang

4

1 reference

25 August 2017

Yunshi Zhong

5

1 reference

25 August 2017

Li Ren

6

1 reference

25 August 2017

Ye Wei

7

1 reference

25 August 2017

Shaochong Zeng

8

1 reference

25 August 2017

Deseng Wan

9

1 reference

25 August 2017

Shu Zheng

10

1 reference

25 August 2017

Society of Surgery

11

1 reference

25 August 2017

Committee of Colorectal Cancer, Chinese Anti-cancer Association

13

1 reference

25 August 2017

publication date

28 July 2011

1 reference

Journal of Cancer Research and Clinical Oncology

25 August 2017

published in

1 reference

25 August 2017

volume

137

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

1379-1396

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-011-0999-8

25 August 2017

exact match

0 references

cites work

Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Chemotherapy for colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

The role of preoperative chemotherapy in patients with resectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Surgical therapy for metastatic disease to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Radiofrequency ablation of unresectable hepatic malignancies: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Chemotherapy-associated hepatotoxicity: do we need to be concerned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Hepatic arterial infusion after curative resection of colorectal cancer metastases: a meta-analysis of prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

PET and PET-CT for evaluation of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Treatment of Metastatic Disease of the Liver: A Skeptic's View

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Regional therapy of hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Therapy for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Hepatectomy for colorectal metastases in the presence of extrahepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Liver resection for colorectal liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Influence of Large Peritumoral Vessels on Outcome of Radiofrequency Ablation of Liver Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Effect of preoperative chemotherapy on liver resection for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

The role of synchronous procedures in the treatment of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Repeated liver resection for recurrent liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Surgical treatment for digestive cancer. Current issues - colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Squamous-cell carcinoma of the anal canal: predictors of treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Adjuvant chemotherapy for colon cancer: evidence on improvement in survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Management of hepatic metastasis from colorectal cancers: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Treatment for colorectal liver metastases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic O

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Local surgical, ablative, and radiation treatment of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Actual 10-year survival after resection of colorectal liver metastases defines cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Treatment of colorectal liver metastases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Making unresectable hepatic colorectal metastases resectable--does it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Strategies to treat primary unresectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Resection of pulmonary metastases from colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Management of involved or close resection margins in 120 patients with colorectal liver metastases: edge cryotherapy can achieve long-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology t

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0999-8

Liver resection for colorectal metastases

21 January 2018

1 reference

12 December 2020

Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect

1 reference

12 December 2020

Evidence-base guideline on management of colorectal liver metastases in the Netherlands

1 reference

12 December 2020

Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Tri

1 reference

12 December 2020

Current therapeutic options for colorectal liver metastases

1 reference

12 December 2020

Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.

1 reference

12 December 2020

The value of radiotherapy for liver metastases

1 reference

12 December 2020

Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab

1 reference

12 December 2020

Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer

1 reference

12 December 2020

Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection

1 reference

12 December 2020

An update and our experience with metastatic liver disease.

1 reference

12 December 2020

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases

1 reference

12 December 2020

Neoadjuvant treatment before resection of liver metastases

1 reference

12 December 2020

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

1 reference

12 December 2020

Radiofrequency ablation of hepatocellular carcinoma.

1 reference

12 December 2020

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases

1 reference

12 December 2020

The TME Trial After a Median Follow-up of 6 Years

1 reference

12 December 2020

Surgical treatment for better prognosis of patients with liver metastases from colorectal cancer

1 reference

12 December 2020

Evolving management of colorectal cancer

1 reference

12 December 2020

Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer

1 reference

12 December 2020

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases

1 reference

12 December 2020

Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology

1 reference

12 December 2020

Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome

1 reference

12 December 2020

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

1 reference

12 December 2020

Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer

1 reference

12 December 2020

Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review

1 reference

12 December 2020

Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.

1 reference

12 December 2020

Practice parameters for colon cancer

1 reference

12 December 2020

Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases.

1 reference

12 December 2020

Major liver resections synchronous with colorectal surgery

1 reference

12 December 2020

Strategies for the treatment of synchronous liver metastasis

1 reference

12 December 2020

Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment

1 reference

12 December 2020

Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands

1 reference

12 December 2020

Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)

1 reference

12 December 2020

Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial

1 reference

12 December 2020

Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer

1 reference

12 December 2020

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

12 December 2020

Management of liver metastases from colorectal cancer.

1 reference

12 December 2020

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer

1 reference

12 December 2020

Simultaneous resection of colorectal primary tumour and synchronous liver metastases

1 reference

12 December 2020

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

1 reference

12 December 2020

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery

1 reference

12 December 2020

Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery

1 reference

12 December 2020

A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases

1 reference

12 December 2020

Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer

1 reference

12 December 2020

Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.

1 reference

12 December 2020

Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases

1 reference

12 December 2020

Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer

1 reference

12 December 2020

Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial

1 reference

12 December 2020

Systemic treatment of colorectal cancer

1 reference

12 December 2020

Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy

1 reference

12 December 2020

Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer

1 reference

12 December 2020

Hepatic resection for colorectal liver metastases.

1 reference

12 December 2020

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival

1 reference

12 December 2020

Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer

1 reference

12 December 2020

Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.

1 reference

12 December 2020

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

1 reference

12 December 2020

10.1007/S00432-011-0999-8

Identifiers

DOI

1 reference

25 August 2017

1 reference